Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fped.2015.00048 http://scihub22266oqcxt.onion/10.3389/fped.2015.00048 C4476261!4476261 !26157786     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26157786 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Front+Pediatr 2015 ; 3 (?): 48 Nephropedia Template TP {{tp|p=26157786 |t=2015. Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy |pdf=|usr=}}{{26157786 }} gab.com Text Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy JO: Front Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=26157786 #FOAvip We present two siblings affected with opsismodysplasia (OPS), a rare skeletal dysplasia caused by mutations in the inositol polyphosphate phosphatase-like 1 gene. The skeletal findings include short stature with postnatal onset micromelia, marked platyspondyly, squared metacarpals, delayed skeletal ossification, metaphyseal cupping, and postnatal micromelia. Respiratory compromise, delayed ambulation, and progressive lower extremity deformities are described. The severity of findings is variable. Renal phosphate wasting is associated with severe bone demineralization and a more severe phenotype. This report represents the first described cases of opsismodysplasia treated with intravenous bisphosphonate (pamidronate). Surgical management for lower extremity deformities associated with OPS is also reviewed. LEVEL OF EVIDENCE: IV Case series. Twit Text FOAVip Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy ????Front Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=26157786 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26157786 #FOAvip English Wikipedia <ref>{{Cite pmid|26157786 }}</ref> Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy #MMPMID26157786 Khwaja A ; Parnell SE ; Ness K ; Bompadre V ; White KK Front Pediatr 2015[]; 3 (?): 48 PMID26157786 show ga We present two siblings affected with opsismodysplasia (OPS), a rare skeletal dysplasia caused by mutations in the inositol polyphosphate phosphatase-like 1 gene. The skeletal findings include short stature with postnatal onset micromelia, marked platyspondyly, squared metacarpals, delayed skeletal ossification, metaphyseal cupping, and postnatal micromelia. Respiratory compromise, delayed ambulation, and progressive lower extremity deformities are described. The severity of findings is variable. Renal phosphate wasting is associated with severe bone demineralization and a more severe phenotype. This report represents the first described cases of opsismodysplasia treated with intravenous bisphosphonate (pamidronate). Surgical management for lower extremity deformities associated with OPS is also reviewed. LEVEL OF EVIDENCE: IV Case series. ?Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphos(epmc).pdf DeepDyve Pubget Overpricing